Apr 30, 4:35 AM EDT

Drugmaker Sanofi sees Q1 profit drop amid leadership change


Buy AP Photo Reprints
Latest News
Controversial surveillance bill comes to vote in France

Jean-Marie Le Pen suspended from French far-right party

Memorial to slain French Jewish man vandalized

French defense chief urges soldiers to admit African abuse

France's Le Pen: Send migrants back across Mediterranean

PARIS (AP) -- Drugmaker Sanofi has reported a slight drop in income in the first quarter amid a leadership transition and lower sales of its Lantus diabetes drug.

The Paris-based company said Thursday its net income was 1.05 billion euros ($1.2 billion), down from 1.12 billion in the first quarter of 2014. Sales were 8.8 billion euros, up 12 percent from last year.

A drop in U.S. sales of Lantus was offset by higher sales in Europe and emerging markets, the company said.

Sanofi expects slight growth this year under new CEO Olivier Brandicourt. His predecessor, Christopher Viehbacher, was sacked in October over his handling of the business, including the loss of U.S. market share for Lantus and his communications with the board.

Sanofi shares were down slightly Thursday morning, to 90.49 euros.

© 2015 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed. Learn more about our Privacy Policy and Terms of Use.